The findings in the present study provide lipid biomarkers of cancerous and normal cells and enhanced insight into the metabolic effects of inactivating APC mutations commonly found in colorectal cancer tumours, and thus could inform therapeutic strategies in the future. The gene discussed is APC; the disease is neoplasm.